Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial
Conclusions: Allogeneic MSC therapy may be a valid alternative for the treatment of degenerative disc disease that is more logistically convenient than the autologous MSC treatment. The intervention is simple, does not require surgery, provides pain relief, and significantly improves disc quality.
Source: Transplantation - Category: Transplant Surgery Tags: Original Clinical Science-General Source Type: research
More News: Anesthesia | Anesthesiology | Back Pain | Chronic Pain | Disability | Gastroschisis Repair | International Medicine & Public Health | Low Back Pain | MRI Scan | Pain | Science | Transplants